Join host Alisyn Camerota as she welcomes Dr. Asaf Maoz from Dana-Farber Cancer Institute to explore the science behind genetic mutations in pancreatic cancer. Building on Episode 9's discussion of the genetic testing journey, this episode dives into hereditary risk and the specific types of mutations patients and families may encounter. 

Dr. Maoz, an attending physician in the Division of Genetics and Prevention and faculty member at Harvard Medical School, explains why genetic testing is now the standard of care, identifies the most common hereditary mutations linked to pancreatic cancer, and discusses what results mean for patients and their families — including when no actionable mutations are found. Learn about the critical role of family history in understanding pancreatic cancer risk.